Skip to main content

Table 1 Clinical characteristics of NAFLD patients and normal controls

From: Identifying potential biomarkers of nonalcoholic fatty liver disease via genome-wide analysis of copy number variation

Characteristics NAFLD (n = 12) Controls (n = 12) p-value
Gender (F/M) 9/3 9/3 1
Age (years) 41.33 ± 11.36 41.00 ± 11.33 0.84
WHR 0.92 ± 0.05 0.83 ± 0.04 < 0.001
BMI (kg/m2) 26.83 ± 2.78 21.44 ± 1.70 < 0.001
ALT 45 ± 48.20 12.25 ± 4.50 0.001
AST 28.5 ± 18.48 19.5 ± 2.84 0.31
TC 5.81 ± 0.70 4.67 ± 0.28 < 0.001
TG 2.07 ± 1.18 0.82 ± 0.24 < 0.001
FBG 5.57 ± 0.67 4.98 ± 0.33 0.009
LDL-C 3.73 ± 0.63 2.97 ± 0.18 0.001
HDL-C 1.29 ± 0.18 1.33 ± 0.21 0.435
  1. BMI body mass index, WHR waist-to-hip ratio, AST serum aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma-glutamyltranspeptidase, FBG serum fasting glucose, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein, HDL-C high-density lipoprotein